Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CNO Financial (CNO) Shares Outstanding (Weighted Average) (2016 - 2026)

CNO Financial (CNO) has 18 years of Shares Outstanding (Weighted Average) data on record, last reported at $94.1 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 6.62% to $94.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $94.1 million, a 6.62% decrease, with the full-year FY2025 number at $97.8 million, down 7.9% from a year prior.
  • Shares Outstanding (Weighted Average) reached $94.1 million in Q1 2026 per CNO's latest filing, down from $97.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CNO hit a ceiling of $118.6 million in Q1 2022 and a floor of $94.1 million in Q1 2026.
  • A 5-year average of $108.1 million and a median of $109.0 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): decreased 11.82% in 2022, then fell 1.09% in 2023.
  • Tracing CNO's Shares Outstanding (Weighted Average) over 5 years: stood at $115.7 million in 2022, then decreased by 2.12% to $113.3 million in 2023, then fell by 6.3% to $106.1 million in 2024, then dropped by 7.9% to $97.8 million in 2025, then decreased by 3.77% to $94.1 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CNO at $94.1 million in Q1 2026, $97.8 million in Q4 2025, and $96.6 million in Q3 2025.